Untangling The Knot: Defining Appropriate Clinical Trial Endpoints and the Path Forward

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Abiomed; Cordis / MedAlliance
• Grant Support/Research Contract - Abbott; Sinomed; Abiomed